Lumenis科医人品牌怎么样 申请店铺

我要投票 Lumenis科医人在美容院行业中的票数:123 更新时间:2025-02-06
Lumenis科医人是哪个国家的品牌?Lumenis科医人医疗激光公司的中国领军人物,科医人医疗激光公司的全球执行副总裁、中国区市场架构的创建者翟琪瑛先生为此做了最好的阐释:“作为能够提供大量高科技医用激光设备的公司,我们的责任是引进高端
Lumenis科医人怎么样

Lumenis科医人医疗激光公司的中国领军人物,科医人医疗激光公司的全球执行副总裁、中国区市场架构的创建者翟琪瑛先生为此做了最好的阐释:“作为能够提供大量高科技医用激光设备的公司,我们的责任是引进高端技术,推广高新产品。目的是为了实现中国医用激光与世界同类技术和产品同步,以改变和美化人们的生活”。“我们绝不向中国提供落后的技术,二流的产品,甚至是二流的服务。我们从数字上关注公司自身的发展,但更在市场培育方面关注大众的认知度。”

同时高素质、专业化的人员构成是公司保持不断创新的源泉。公司把新产品的研制、开发放在首位,每年以销售额的5%投入研发,研发今后一两年、两三年以至十年后市场上所需的激光产品。为了缩短技术转化成产品的过程,加快创新步伐,公司同大型的医疗机构、著名的临床医生及高等院校等建立了紧密的合作关系。同时,在全球科医人触角所及之处建立实验基地。这种理论与实践积极互动的模式是Lumenis科医人医疗激光产品始终勇立潮头的基石。

此外提供高品质多方面的服务,更是Lumenis制胜的法宝。它包含三个层面的内容:一是技术上,在提供高端精良产品的同时,也提供高质量的产品安装、准确的故障处理、良好的配件供应及对医师高水平的技术培训等服务。这些都构成了医疗激光产品得以正确操作的有力保障。二是对医患双方的服务,要帮助医生了解医疗激光产品的工作原理,它为什么能治疗疾病,能治疗什么病,操作的过程中应注意的事项,医生自身的防护等;对于患者,则经常举行一些活动,让人们了解有关激光的基本知识,消除人们的恐惧心理。三是公司除了积极参加国内外学术年会外,还定期举行学术交流会和研讨会,邀请专家讲课,进行技术交流,甚至手术演示等。

Zhai Qiying, China's leading figure of Lumenis medical laser company, global executive vice president of medical laser company and founder of China's market structure, made the best explanation for this: "as a company that can provide a large number of high-tech medical laser equipment, our responsibility is to introduce high-end technology and promote high-tech products. The purpose is to realize the synchronization of Chinese medical laser with similar technologies and products in the world, so as to change and beautify people's lives. ". "We will never provide China with backward technology, second-class products or even second-class services. We pay attention to the company's own development digitally, but we pay more attention to the public's awareness in market cultivation. " At the same time, high-quality, professional personnel composition is the source of continuous innovation of the company. The company puts the research and development of new products in the first place, and invests 5% of the sales volume in the research and development every year, and researches and develops the laser products needed in the market in the next one or two years, two or three years or even ten years. In order to shorten the process of technology into products and accelerate the pace of innovation, the company has established close cooperation with large medical institutions, famous clinicians and colleges and universities. At the same time, an experimental base should be set up where the global scientific and medical personnel touch. This mode of active interaction between theory and practice is the cornerstone of Lumenis medical laser products. In addition, providing high-quality and various services is the magic weapon for Lumenis to win. It includes three aspects: first, technically, it provides high-end and excellent products, as well as high-quality product installation, accurate troubleshooting, good accessories supply and high-level technical training for doctors. All these constitute a powerful guarantee for the correct operation of medical laser products. Second, for the service of both doctors and patients, it is necessary to help doctors understand the working principle of medical laser products, why it can treat diseases, what diseases it can treat, matters needing attention in the process of operation, and the protection of doctors themselves; for patients, some activities are often held to let people know the basic knowledge of laser and eliminate people's fear. Third, in addition to actively participating in the annual academic conferences at home and abroad, the company also holds regular academic exchange meetings and seminars, invites experts to give lectures, technical exchanges, and even operation demonstrations.

本文链接: https://brand.waitui.com/a028eb408.html 联系电话:010-57376677

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

59分钟前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

59分钟前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

59分钟前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

59分钟前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

59分钟前

本页详细列出关于飞顿医疗的品牌信息,含品牌所属公司介绍,飞顿医疗所处行业的品牌地位及优势。
咨询